Lugol's iodine

Revision as of 17:02, 9 August 2012 by WikiBot (talk | contribs) (Robot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

WikiDoc Resources for Lugol's iodine

Articles

Most recent articles on Lugol's iodine

Most cited articles on Lugol's iodine

Review articles on Lugol's iodine

Articles on Lugol's iodine in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Lugol's iodine

Images of Lugol's iodine

Photos of Lugol's iodine

Podcasts & MP3s on Lugol's iodine

Videos on Lugol's iodine

Evidence Based Medicine

Cochrane Collaboration on Lugol's iodine

Bandolier on Lugol's iodine

TRIP on Lugol's iodine

Clinical Trials

Ongoing Trials on Lugol's iodine at Clinical Trials.gov

Trial results on Lugol's iodine

Clinical Trials on Lugol's iodine at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Lugol's iodine

NICE Guidance on Lugol's iodine

NHS PRODIGY Guidance

FDA on Lugol's iodine

CDC on Lugol's iodine

Books

Books on Lugol's iodine

News

Lugol's iodine in the news

Be alerted to news on Lugol's iodine

News trends on Lugol's iodine

Commentary

Blogs on Lugol's iodine

Definitions

Definitions of Lugol's iodine

Patient Resources / Community

Patient resources on Lugol's iodine

Discussion groups on Lugol's iodine

Patient Handouts on Lugol's iodine

Directions to Hospitals Treating Lugol's iodine

Risk calculators and risk factors for Lugol's iodine

Healthcare Provider Resources

Symptoms of Lugol's iodine

Causes & Risk Factors for Lugol's iodine

Diagnostic studies for Lugol's iodine

Treatment of Lugol's iodine

Continuing Medical Education (CME)

CME Programs on Lugol's iodine

International

Lugol's iodine en Espanol

Lugol's iodine en Francais

Business

Lugol's iodine in the Marketplace

Patents on Lugol's iodine

Experimental / Informatics

List of terms related to Lugol's iodine


Lugol's iodine, also known as Lugol's solution, first made in 1829, is a solution of iodine named after the French physician J.G.A. Lugol. Lugol's iodine solution is often used as an antiseptic and disinfectant, a starch indicator, to replenish iodine deficiency, to protect the thyroid gland from radioactive materials (e.g. "fallout"), and for emergency disinfection of drinking water.[1]

Lugol's was often used in the treatment of gout and was used as a first line treatment for hypothyroidism in adults.

It consists of 10% iodine (I2) and 10% potassium iodide (KI) in 80% distilled water with a total iodine content of 130 mg/mL. Potassium iodide makes the iodine water soluble through the formation of the I3- ion. It is obtained from chemists and pharmacists who are licensed to prepare and dispense the solution.

This solution is also used as an indicator to test for the presence of starches in organic compounds, with which it reacts by turning a dark-blue/black. IKI will stain starches due to its interaction with the coil structure of the polysaccharide. IKI solution will not detect simple sugars such as glucose or fructose. In the pathologic condition amyloidosis, amyloid deposits can be so abundant that affected organs will also stain grossly positive for the Lugol reaction for starch. Other names for Lugol's solution are IKI (Iodine Potassium-Iodide); Iodine, Strong solution (Systemic); Aqueous Iodine Solution BP.

It can be used as a cell stain, making the cell nuclei more visible and for preserving phytoplankton samples.

Applications

Historically, Lugol's iodine solution has been widely available and used for a number of health problems with some precautions.[2] Lugol's is sometimes prescribed in a variety of alternative medical treatments.[3][4]

In the United States of America, Lugol's solution was previously unregulated and available over the counter as a general reagent, an antiseptic, a preservative,[5] or as a medicament for human or veterinary application. However, effective August 1, 2007, the DEA now regulates Lugol's solution (and, in fact, all iodine solutions containing greater than 2.2% iodine) as a List I precursor because it may potentially be used in the illicit production of methamphetamine.[6] By contrast, Lugol's iodine solution is available over the counter in Canada and Mexico, for example.

Following the Chernobyl nuclear reactor disaster in April, 1986, Lugol's iodine solution was administered to 10.5 million children and 7 million adults in Poland[7] as a prophylactic measure against accumulation of radioactive iodine-131 in the thyroid.

Many organs in the body require iodine to function normally, especially breast tissue. Studies have confirmed a link between fibrocystic breast disease and lack of iodine in a woman's diet.[8] Recent studies have confirmed an increase in breast cancer since manufacturers eliminated iodine from bread approximately 20 years ago and replaced it with bromine. Bromine is toxic to the thyroid gland as well.

Lugol's iodine is sometimes used to treat thyroid storm, and may be taken pre-operatively.

Lugol's solution can also be used in various experiments to observe how a cell membrane uses osmosis and diffusion.

References

  1. [1] Higdon, J., "Micronutrient Information Center: Iodine," Linux Pauling Institute/Oregon State University; April, 2003 (revised by Drake, V.J., July, 2007).
  2. [2] Drugs.com, "Lugol's Solution."
  3. [3] Optimox.com, "Iodine."
  4. [4] Jcrows.com, "Iodine."
  5. [5] Hawkins et al., "Change in cyanobacterial biovolume due to preservation by Lugol's Iodine," Harmful Algae, Volume 4, Issue 6, pp. 1033-1043; November, 2005.
  6. [6] US DEA, "Final Rule: Changes in the Regulation of Iodine Crystals and Chemical Mixtures Containing Over 2.2 Percent Iodine," Federal Register, Volume 72, Number 126; July 2, 2007 (FR Doc E7-12736).
  7. [7] US FDA, "Potassium Iodide as a Thyroid Blocking Agent in Radiation Emergencies," U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER); December, 2001.
  8. [8] Howenstine, J., "THYROID HORMONE THERAPY APPEARS TO CAUSE BREAST CANCER," NewsWithViews.com; July 27, 2006.

See also

http://www.britannica.com/eb/article-9049302/Lugol's-solution


cs:Lugolovo činidlo de:Iod-Kaliumiodid-Lösung he:לוגול nl:Lugos

Template:WH Template:WS